246 related articles for article (PubMed ID: 25936721)
1. Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure.
Cobos-Trigueros N; Solé M; Castro P; Torres JL; Hernández C; Rinaudo M; Fernández S; Soriano Á; Nicolás JM; Mensa J; Vila J; Martínez JA
Crit Care; 2015 May; 19(1):218. PubMed ID: 25936721
[TBL] [Abstract][Full Text] [Related]
2. Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients.
Martínez JA; Delgado E; Martí S; Marco F; Vila J; Mensa J; Torres A; Codina C; Trilla A; Soriano A; Alquezar A; Castro P; Nicolás JM
Intensive Care Med; 2009 Mar; 35(3):439-47. PubMed ID: 18936910
[TBL] [Abstract][Full Text] [Related]
3. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hospitalized patients with resistant or multidrug-resistant
Raman G; Avendano EE; Chan J; Merchant S; Puzniak L
Antimicrob Resist Infect Control; 2018; 7():79. PubMed ID: 29997889
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units.
Ong DS; Jongerden IP; Buiting AG; Leverstein-van Hall MA; Speelberg B; Kesecioglu J; Bonten MJ
Crit Care Med; 2011 Nov; 39(11):2458-63. PubMed ID: 21705892
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Mixing versus a Cycling Strategy of Antibiotic Use in Critically-Ill Medical Patients: Impact on Acquisition of Resistant Microorganisms and Clinical Outcomes.
Cobos-Trigueros N; Solé M; Castro P; Torres JL; Rinaudo M; De Lazzari E; Morata L; Hernández C; Fernández S; Soriano A; Nicolás JM; Mensa J; Vila J; Martínez JA
PLoS One; 2016; 11(3):e0150274. PubMed ID: 26982807
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients.
Pettigrew MM; Gent JF; Kong Y; Halpin AL; Pineles L; Harris AD; Johnson JK
Clin Infect Dis; 2019 Aug; 69(4):604-613. PubMed ID: 30383203
[TBL] [Abstract][Full Text] [Related]
8. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
Lodise TP; Miller CD; Graves J; Furuno JP; McGregor JC; Lomaestro B; Graffunder E; McNutt LA
Antimicrob Agents Chemother; 2007 Feb; 51(2):417-22. PubMed ID: 17158943
[TBL] [Abstract][Full Text] [Related]
9. A Combination Antibiogram Evaluation for
Puzniak L; DePestel DD; Srinivasan A; Ye G; Murray J; Merchant S; DeRyke CA; Gupta V
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917987
[No Abstract] [Full Text] [Related]
10. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
[TBL] [Abstract][Full Text] [Related]
11. The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.
Zou Y; Lian J; Di Y; You H; Yao H; Liu J; Dong Y
Int J Clin Pharm; 2018 Feb; 40(1):175-182. PubMed ID: 29134489
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units.
Martínez JA; Nicolás JM; Marco F; Horcajada JP; Garcia-Segarra G; Trilla A; Codina C; Torres A; Mensa J
Crit Care Med; 2006 Feb; 34(2):329-36. PubMed ID: 16424711
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients.
Peña C; Suarez C; Tubau F; Dominguez A; Sora M; Pujol M; Gudiol F; Ariza J
Eur J Clin Microbiol Infect Dis; 2009 May; 28(5):519-22. PubMed ID: 18949495
[TBL] [Abstract][Full Text] [Related]
14. Endemic multidrug-resistant Pseudomonas aeruginosa in critically ill patients.
Ortega B; Groeneveld AB; Schultsz C
Infect Control Hosp Epidemiol; 2004 Oct; 25(10):825-31. PubMed ID: 15518023
[TBL] [Abstract][Full Text] [Related]
15. Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis.
Baditoiu L; Axente C; Lungeanu D; Muntean D; Horhat F; Moldovan R; Hogea E; Bedreag O; Sandesc D; Licker M
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):71. PubMed ID: 29132352
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors.
Trinh TD; Zasowski EJ; Claeys KC; Lagnf AM; Kidambi S; Davis SL; Rybak MJ
Diagn Microbiol Infect Dis; 2017 Sep; 89(1):61-66. PubMed ID: 28716451
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic-Induced Within-Host Resistance Development of Gram-Negative Bacteria in Patients Receiving Selective Decontamination or Standard Care.
Noteboom Y; Ong DS; Oostdijk EA; Schultz MJ; de Jonge E; Purmer I; Bergmans D; Fijen JW; Kesecioglu J; Bonten MJ
Crit Care Med; 2015 Dec; 43(12):2582-8. PubMed ID: 26448616
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa acquisition on an intensive care unit: relationship between antibiotic selective pressure and patients' environment.
Boyer A; Doussau A; Thiébault R; Venier AG; Tran V; Boulestreau H; Bébéar C; Vargas F; Hilbert G; Gruson D; Rogues AM
Crit Care; 2011; 15(1):R55. PubMed ID: 21306623
[TBL] [Abstract][Full Text] [Related]
19. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study.
Venier AG; Leroyer C; Slekovec C; Talon D; Bertrand X; Parer S; Alfandari S; Guerin JM; Megarbane B; Lawrence C; Clair B; Lepape A; Perraud M; Cassier P; Trivier D; Boyer A; Dubois V; Asselineau J; Rogues AM; Thiébaut R;
J Hosp Infect; 2014 Oct; 88(2):103-8. PubMed ID: 25155240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
